 | • レポートコード：GIR201111317 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、消化管間質腫瘍（GIST）治療薬の世界市場を調査対象にし、消化管間質腫瘍（GIST）治療薬の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（アンカセルチブ、塩酸アナグレリドCR、APG-1351、ビニメチニブ、その他）、用途別分析（クリニック、病院、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Ariad Pharmaceuticals, Inc.、Chipscreen Biosciences Ltd、Astex Pharmaceuticals, Inc.、Arog Pharmaceuticals, Inc.、Calithera Biosciences, Inc.、Array BioPharma Inc.、F. Hoffmann-La Roche Ltd.、Boston Biomedical, Inc.、Blueprint Medicines Corporation、Deciphera Pharmaceuticals, LLC、Natco Pharma Limited、Omeros Corporation、Horizon Pharma Plc、Nerviano Medical Sciences S.r.l.、Kolltan Pharmaceuticals, Inc.、Immunicum AB、Novartis AG、Jiangsu Hengrui Medicine Co., Ltd. ・メーカー別販売量、売上、市場シェア ・消化管間質腫瘍（GIST）治療薬の地域別市場分析 ・消化管間質腫瘍（GIST）治療薬の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・消化管間質腫瘍（GIST）治療薬のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・消化管間質腫瘍（GIST）治療薬のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・消化管間質腫瘍（GIST）治療薬の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・消化管間質腫瘍（GIST）治療薬の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・消化管間質腫瘍（GIST）治療薬の種類別市場規模2015-2020：アンカセルチブ、塩酸アナグレリドCR、APG-1351、ビニメチニブ、その他 ・消化管間質腫瘍（GIST）治療薬の用途別市場規模2015-2020：クリニック、病院、その他 ・消化管間質腫瘍（GIST）治療薬の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Gastrointestinal Stromal Tumor (GIST) Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Gastrointestinal Stromal Tumor (GIST) Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Gastrointestinal Stromal Tumor (GIST) Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Gastrointestinal Stromal Tumor (GIST) Drug market has been segmented into
Amcasertib
Anagrelide hydrochloride CR
APG-1351
Binimetinib
Others
By Application, Gastrointestinal Stromal Tumor (GIST) Drug has been segmented into:
Clinic
Hospital
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Gastrointestinal Stromal Tumor (GIST) Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Gastrointestinal Stromal Tumor (GIST) Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Gastrointestinal Stromal Tumor (GIST) Drug market.
The report offers in-depth assessment of the growth and other aspects of the Gastrointestinal Stromal Tumor (GIST) Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Gastrointestinal Stromal Tumor (GIST) Drug Market Share Analysis
Gastrointestinal Stromal Tumor (GIST) Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Gastrointestinal Stromal Tumor (GIST) Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Gastrointestinal Stromal Tumor (GIST) Drug sales, revenue and market share for each player covered in this report.
The major players covered in Gastrointestinal Stromal Tumor (GIST) Drug are:
Ariad Pharmaceuticals, Inc.
Chipscreen Biosciences Ltd
Astex Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc.
Calithera Biosciences, Inc.
Array BioPharma Inc.
F. Hoffmann-La Roche Ltd.
Boston Biomedical, Inc.
Blueprint Medicines Corporation
Deciphera Pharmaceuticals, LLC
Natco Pharma Limited
Omeros Corporation
Horizon Pharma Plc
Nerviano Medical Sciences S.r.l.
Kolltan Pharmaceuticals, Inc.
Immunicum AB
Novartis AG
Jiangsu Hengrui Medicine Co., Ltd.
Among other players domestic and global, Gastrointestinal Stromal Tumor (GIST) Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gastrointestinal Stromal Tumor (GIST) Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Gastrointestinal Stromal Tumor (GIST) Drug, with price, sales, revenue and global market share of Gastrointestinal Stromal Tumor (GIST) Drug in 2018 and 2019.
Chapter 3, the Gastrointestinal Stromal Tumor (GIST) Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gastrointestinal Stromal Tumor (GIST) Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Gastrointestinal Stromal Tumor (GIST) Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Gastrointestinal Stromal Tumor (GIST) Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Gastrointestinal Stromal Tumor (GIST) Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Amcasertib
1.2.3 Anagrelide hydrochloride CR
1.2.4 APG-1351
1.2.5 Binimetinib
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Overview of Global Gastrointestinal Stromal Tumor (GIST) Drug Market
1.4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Ariad Pharmaceuticals, Inc.
2.1.1 Ariad Pharmaceuticals, Inc. Details
2.1.2 Ariad Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Ariad Pharmaceuticals, Inc. SWOT Analysis
2.1.4 Ariad Pharmaceuticals, Inc. Product and Services
2.1.5 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Chipscreen Biosciences Ltd
2.2.1 Chipscreen Biosciences Ltd Details
2.2.2 Chipscreen Biosciences Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Chipscreen Biosciences Ltd SWOT Analysis
2.2.4 Chipscreen Biosciences Ltd Product and Services
2.2.5 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Astex Pharmaceuticals, Inc.
2.3.1 Astex Pharmaceuticals, Inc. Details
2.3.2 Astex Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Astex Pharmaceuticals, Inc. SWOT Analysis
2.3.4 Astex Pharmaceuticals, Inc. Product and Services
2.3.5 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Arog Pharmaceuticals, Inc.
2.4.1 Arog Pharmaceuticals, Inc. Details
2.4.2 Arog Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Arog Pharmaceuticals, Inc. SWOT Analysis
2.4.4 Arog Pharmaceuticals, Inc. Product and Services
2.4.5 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Calithera Biosciences, Inc.
2.5.1 Calithera Biosciences, Inc. Details
2.5.2 Calithera Biosciences, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Calithera Biosciences, Inc. SWOT Analysis
2.5.4 Calithera Biosciences, Inc. Product and Services
2.5.5 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Array BioPharma Inc.
2.6.1 Array BioPharma Inc. Details
2.6.2 Array BioPharma Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Array BioPharma Inc. SWOT Analysis
2.6.4 Array BioPharma Inc. Product and Services
2.6.5 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 F. Hoffmann-La Roche Ltd.
2.7.1 F. Hoffmann-La Roche Ltd. Details
2.7.2 F. Hoffmann-La Roche Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 F. Hoffmann-La Roche Ltd. SWOT Analysis
2.7.4 F. Hoffmann-La Roche Ltd. Product and Services
2.7.5 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Boston Biomedical, Inc.
2.8.1 Boston Biomedical, Inc. Details
2.8.2 Boston Biomedical, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Boston Biomedical, Inc. SWOT Analysis
2.8.4 Boston Biomedical, Inc. Product and Services
2.8.5 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Blueprint Medicines Corporation
2.9.1 Blueprint Medicines Corporation Details
2.9.2 Blueprint Medicines Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Blueprint Medicines Corporation SWOT Analysis
2.9.4 Blueprint Medicines Corporation Product and Services
2.9.5 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Deciphera Pharmaceuticals, LLC
2.10.1 Deciphera Pharmaceuticals, LLC Details
2.10.2 Deciphera Pharmaceuticals, LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Deciphera Pharmaceuticals, LLC SWOT Analysis
2.10.4 Deciphera Pharmaceuticals, LLC Product and Services
2.10.5 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Natco Pharma Limited
2.11.1 Natco Pharma Limited Details
2.11.2 Natco Pharma Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Natco Pharma Limited SWOT Analysis
2.11.4 Natco Pharma Limited Product and Services
2.11.5 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Omeros Corporation
2.12.1 Omeros Corporation Details
2.12.2 Omeros Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Omeros Corporation SWOT Analysis
2.12.4 Omeros Corporation Product and Services
2.12.5 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Horizon Pharma Plc
2.13.1 Horizon Pharma Plc Details
2.13.2 Horizon Pharma Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Horizon Pharma Plc SWOT Analysis
2.13.4 Horizon Pharma Plc Product and Services
2.13.5 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Nerviano Medical Sciences S.r.l.
2.14.1 Nerviano Medical Sciences S.r.l. Details
2.14.2 Nerviano Medical Sciences S.r.l. Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Nerviano Medical Sciences S.r.l. SWOT Analysis
2.14.4 Nerviano Medical Sciences S.r.l. Product and Services
2.14.5 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Kolltan Pharmaceuticals, Inc.
2.15.1 Kolltan Pharmaceuticals, Inc. Details
2.15.2 Kolltan Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Kolltan Pharmaceuticals, Inc. SWOT Analysis
2.15.4 Kolltan Pharmaceuticals, Inc. Product and Services
2.15.5 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Immunicum AB
2.16.1 Immunicum AB Details
2.16.2 Immunicum AB Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Immunicum AB SWOT Analysis
2.16.4 Immunicum AB Product and Services
2.16.5 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Novartis AG
2.17.1 Novartis AG Details
2.17.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Novartis AG SWOT Analysis
2.17.4 Novartis AG Product and Services
2.17.5 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Jiangsu Hengrui Medicine Co., Ltd.
2.18.1 Jiangsu Hengrui Medicine Co., Ltd. Details
2.18.2 Jiangsu Hengrui Medicine Co., Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Jiangsu Hengrui Medicine Co., Ltd. SWOT Analysis
2.18.4 Jiangsu Hengrui Medicine Co., Ltd. Product and Services
2.18.5 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Gastrointestinal Stromal Tumor (GIST) Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Gastrointestinal Stromal Tumor (GIST) Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020)
4.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020)
4.5 South America Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Market Share by Country
5.1.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020)
5.3 Canada Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020)
6.3 UK Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020)
6.4 France Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020)
6.5 Russia Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020)
6.6 Italy Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020)
7.3 Japan Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020)
7.4 Korea Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020)
7.5 India Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020)
7.7 Australia Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Market Share by Country
8.1.1 South America Gastrointestinal Stromal Tumor (GIST) Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales and Market Share by Type (2015-2020)
10.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Type (2015-2020)
11 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Segment by Application
11.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2015-2020)
11.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Application (2015-2020)
11.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast (2021-2025)
12.2.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast (2021-2025)
12.2.4 South America Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast (2021-2025)
12.3 Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast by Type (2021-2025)
12.3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share Forecast by Type (2021-2025)
12.4 Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast by Application (2021-2025)
12.4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Gastrointestinal Stromal Tumor (GIST) Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Ariad Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 8. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Major Business
Table 9. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Total Revenue (USD Million) (2018-2019)
Table 10. Ariad Pharmaceuticals, Inc. SWOT Analysis
Table 11. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
Table 12. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Chipscreen Biosciences Ltd Basic Information, Manufacturing Base and Competitors
Table 14. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Major Business
Table 15. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Total Revenue (USD Million) (2018-2019)
Table 16. Chipscreen Biosciences Ltd SWOT Analysis
Table 17. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
Table 18. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Astex Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 20. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Major Business
Table 21. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Total Revenue (USD Million) (2018-2019)
Table 22. Astex Pharmaceuticals, Inc. SWOT Analysis
Table 23. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
Table 24. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Arog Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 26. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Major Business
Table 27. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Total Revenue (USD Million) (2018-2019)
Table 28. Arog Pharmaceuticals, Inc. SWOT Analysis
Table 29. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
Table 30. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Calithera Biosciences, Inc. Basic Information, Manufacturing Base and Competitors
Table 32. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Major Business
Table 33. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Total Revenue (USD Million) (2018-2019)
Table 34. Calithera Biosciences, Inc. SWOT Analysis
Table 35. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
Table 36. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Array BioPharma Inc. Basic Information, Manufacturing Base and Competitors
Table 38. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Major Business
Table 39. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Total Revenue (USD Million) (2018-2019)
Table 40. Array BioPharma Inc. SWOT Analysis
Table 41. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
Table 42. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
Table 44. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Major Business
Table 45. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Total Revenue (USD Million) (2018-2019)
Table 46. F. Hoffmann-La Roche Ltd. SWOT Analysis
Table 47. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
Table 48. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Boston Biomedical, Inc. Basic Information, Manufacturing Base and Competitors
Table 50. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Major Business
Table 51. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Total Revenue (USD Million) (2018-2019)
Table 52. Boston Biomedical, Inc. SWOT Analysis
Table 53. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
Table 54. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Blueprint Medicines Corporation Basic Information, Manufacturing Base and Competitors
Table 56. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Major Business
Table 57. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Total Revenue (USD Million) (2018-2019)
Table 58. Blueprint Medicines Corporation SWOT Analysis
Table 59. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
Table 60. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Deciphera Pharmaceuticals, LLC Basic Information, Manufacturing Base and Competitors
Table 62. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Major Business
Table 63. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Total Revenue (USD Million) (2018-2019)
Table 64. Deciphera Pharmaceuticals, LLC SWOT Analysis
Table 65. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
Table 66. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Natco Pharma Limited Basic Information, Manufacturing Base and Competitors
Table 68. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Major Business
Table 69. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Total Revenue (USD Million) (2018-2019)
Table 70. Natco Pharma Limited SWOT Analysis
Table 71. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
Table 72. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Omeros Corporation Basic Information, Manufacturing Base and Competitors
Table 74. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Major Business
Table 75. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Total Revenue (USD Million) (2018-2019)
Table 76. Omeros Corporation SWOT Analysis
Table 77. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
Table 78. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Horizon Pharma Plc Basic Information, Manufacturing Base and Competitors
Table 80. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Major Business
Table 81. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Total Revenue (USD Million) (2018-2019)
Table 82. Horizon Pharma Plc SWOT Analysis
Table 83. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
Table 84. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Nerviano Medical Sciences S.r.l. Basic Information, Manufacturing Base and Competitors
Table 86. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Major Business
Table 87. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Total Revenue (USD Million) (2018-2019)
Table 88. Nerviano Medical Sciences S.r.l. SWOT Analysis
Table 89. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
Table 90. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Kolltan Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 92. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Major Business
Table 93. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Total Revenue (USD Million) (2018-2019)
Table 94. Kolltan Pharmaceuticals, Inc. SWOT Analysis
Table 95. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
Table 96. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Immunicum AB Basic Information, Manufacturing Base and Competitors
Table 98. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Major Business
Table 99. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Total Revenue (USD Million) (2018-2019)
Table 100. Immunicum AB SWOT Analysis
Table 101. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
Table 102. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 104. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Major Business
Table 105. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Total Revenue (USD Million) (2018-2019)
Table 106. Novartis AG SWOT Analysis
Table 107. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
Table 108. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Type and Application
Table 110. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Major Business
Table 111. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Total Revenue (USD Million) (2018-2019)
Table 112. Jiangsu Hengrui Medicine Co., Ltd. SWOT Analysis
Table 113. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
Table 114. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 115. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Manufacturer (2018-2019) (K Pcs)
Table 116. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 117. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Regions (2015-2020) (K Pcs)
Table 118. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Regions (2015-2020)
Table 119. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Regions (2015-2020) (USD Million)
Table 120. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Countries (2015-2020) (K Pcs)
Table 121. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Countries (2015-2020)
Table 122. North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Countries (2015-2020) (USD Million)
Table 123. North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Countries (2015-2020)
Table 124. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Countries (2015-2020) (K Pcs)
Table 125. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Countries (2015-2020)
Table 126. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Countries (2015-2020) (USD Million)
Table 127. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Regions (2015-2020) (K Pcs)
Table 128. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Regions (2015-2020)
Table 129. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Regions (2015-2020) (USD Million)
Table 130. South America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Countries (2015-2020) (K Pcs)
Table 131. South America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Countries (2015-2020)
Table 132. South America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Countries (2015-2020) (USD Million)
Table 133. South America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Countries (2015-2020)
Table 134. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Countries (2015-2020) (K Pcs)
Table 135. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Countries (2015-2020)
Table 136. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Countries (2015-2020) (USD Million)
Table 137. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Countries (2015-2020)
Table 138. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2015-2020) (K Pcs)
Table 139. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Type (2015-2020)
Table 140. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2015-2020) (USD Million)
Table 141. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Type (2015-2020)
Table 142. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2015-2020) (K Pcs)
Table 143. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Application (2015-2020)
Table 144. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Regions (2021-2025) (K Pcs)
Table 145. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share Forecast by Regions (2021-2025)
Table 146. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Type (2021-2025) (K Pcs)
Table 147. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share Forecast by Type (2021-2025)
Table 148. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Application (2021-2025)
Table 149. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share Forecast by Application (2021-2025)
Table 150. Direct Channel Pros & Cons
Table 151. Indirect Channel Pros & Cons
Table 152. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Gastrointestinal Stromal Tumor (GIST) Drug Picture
Figure 2. Global Sales Market Share of Gastrointestinal Stromal Tumor (GIST) Drug by Type in 2019
Figure 3. Amcasertib Picture
Figure 4. Anagrelide hydrochloride CR Picture
Figure 5. APG-1351 Picture
Figure 6. Binimetinib Picture
Figure 7. Others Picture
Figure 8. Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application in 2018
Figure 9. Clinic Picture
Figure 10. Hospital Picture
Figure 11. Others Picture
Figure 12. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Manufacturer in 2019
Figure 33. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Gastrointestinal Stromal Tumor (GIST) Drug Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Gastrointestinal Stromal Tumor (GIST) Drug Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 38. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Regions (2015-2020)
Figure 40. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Regions in 2018
Figure 41. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020)
Figure 42. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020)
Figure 44. South America Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020)
Figure 46. North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Countries (2015-2020)
Figure 48. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Countries in 2018
Figure 49. North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Countries in 2018
Figure 51. United States Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 52. Canada Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Mexico Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Countries in 2019
Figure 57. Germany Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. UK Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. France Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. Russia Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Italy Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Regions 2019
Figure 65. China Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Korea Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. India Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. South America Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Countries in 2019
Figure 72. South America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Countries in 2019
Figure 73. Brazil Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 74. Argentina Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 75. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. Egypt Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Turkey Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. South Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2021-2025) (K Pcs)
Figure 84. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast (2021-2025) (K Pcs)
Figure 86. Europe Sales Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast (2021-2025) (K Pcs)
Figure 87. Asia-Pacific Sales Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast (2021-2025) (K Pcs)
Figure 88. South America Sales Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast (2021-2025) (K Pcs)
Figure 89. Middle East & Africa Sales Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast (2021-2025) (K Pcs)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
スニチニブ薬の世界市場 2020年 Market Overview The global Sunitinib Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Sunitinib Drug market report p…- 間質細胞由来因子1の世界市場 2020年 Market Overview The global Stromal Cell Derived Factor 1 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Stromal Cell De…
- 神経内分泌腫瘍治療薬の世界市場 2020年 Market Overview The global Neuroendocrine Tumor Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Neuroendocrine Tumo…
- 腫瘍壊死因子阻害薬の世界市場 2020年 Market Overview The global Tumor Necrosis Factor Inhibitors Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tumor N…
- OTC胃腸製品の世界市場 2020年 Market Overview The global OTC Gastrointestinal Products market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The OTC Gastrointes…